PCS Table XW1

24 procedure codes are mapped to this table.

  • Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach, New Technology Group 5

  • Transfusion of Marnetegragene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 10

  • Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8

  • Transfusion of Omidubicel into Peripheral Vein, Percutaneous Approach, New Technology Group 8

  • Transfusion of High-Dose Intravenous Immune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7

  • Transfusion of Hyperimmune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7

  • Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8

  • Transfusion of Atidarsagene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8

  • Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9

  • Transfusion of Exagamglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8

  • Transfusion of Mozafancogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 11

  • Transfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Peripheral Vein, Percutaneous Approach, New Technology Group 11

  • Transfusion of Convalescent Plasma (Nonautologous) into Central Vein, Percutaneous Approach, New Technology Group 5

  • Transfusion of Marnetegragene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 10

  • Transfusion of Betibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8

  • Transfusion of Omidubicel into Central Vein, Percutaneous Approach, New Technology Group 8

  • Transfusion of High-Dose Intravenous Immune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7

  • Transfusion of Hyperimmune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7

  • Transfusion of OTL-103 into Central Vein, Percutaneous Approach, New Technology Group 8

  • Transfusion of Atidarsagene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8

  • Transfusion of Lovotibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 9

  • Transfusion of Exagamglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8

  • Transfusion of Mozafancogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 11

  • Transfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Central Vein, Percutaneous Approach, New Technology Group 11